Phase I Trial Evaluating the Safety of the Dietary Supplement Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

Investigator: Jun Zhang

Study Coordinator: Derek Cole

Status: Enrolling

ClinicalTrials.gov Number: N/A

Phone: 713.441.5607

Protocol Number: PRO00037422

Description

The goal of this research study is to find the highest, safest dose of honokiol (a type of dietary supplement) that can be given to patients who have resectable early-stage NSCLC. Researchers also want to learn if giving honokiol before surgery can help to control the tumor.
More to Explore